Shabaana A. Khader

16.0k total citations · 3 hit papers
117 papers, 10.1k citations indexed

About

Shabaana A. Khader is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Shabaana A. Khader has authored 117 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Immunology, 73 papers in Infectious Diseases and 49 papers in Epidemiology. Recurrent topics in Shabaana A. Khader's work include Tuberculosis Research and Epidemiology (58 papers), Mycobacterium research and diagnosis (30 papers) and Immunodeficiency and Autoimmune Disorders (22 papers). Shabaana A. Khader is often cited by papers focused on Tuberculosis Research and Epidemiology (58 papers), Mycobacterium research and diagnosis (30 papers) and Immunodeficiency and Autoimmune Disorders (22 papers). Shabaana A. Khader collaborates with scholars based in United States, Mexico and Canada. Shabaana A. Khader's co-authors include Andrea M. Cooper, Jay K. Kolls, Javier Rangel‐Moreno, Sarah L. Gaffen, John E. Pearl, Troy D. Randall, Samantha Slight, Radha Gopal, Deepak Kaushal and Yinyao Lin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Shabaana A. Khader

115 papers receiving 10.0k citations

Hit Papers

IL-23 and IL-17 in the establishment of protective pulmon... 2007 2026 2013 2019 2007 2016 2016 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
    2007 1.1k citations Shabaana A. Khader, Javier Rangel‐Moreno et al. Nature Immunology profile →
  2. Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
    2016 1.1k citations Shabaana A. Khader, Edward J. Pearce et al. profile →
  3. Cytokines and Chemokines inMycobacterium tuberculosisInfection
    2016 294 citations Shabaana A. Khader et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shabaana A. Khader United States 49 6.0k 4.5k 3.6k 1.8k 939 117 10.1k
Carl G. Feng Australia 49 5.5k 0.9× 3.2k 0.7× 3.0k 0.8× 1.5k 0.8× 711 0.8× 100 8.7k
Javier Rangel‐Moreno United States 41 4.8k 0.8× 2.3k 0.5× 2.1k 0.6× 1.1k 0.6× 655 0.7× 102 7.5k
Frédéric Altare France 41 4.0k 0.7× 3.6k 0.8× 3.5k 1.0× 1.3k 0.7× 1.3k 1.4× 85 8.0k
Maziar Divangahi Canada 43 5.1k 0.9× 3.2k 0.7× 2.3k 0.6× 2.6k 1.4× 760 0.8× 114 9.2k
Samuel M. Behar United States 59 7.8k 1.3× 5.0k 1.1× 3.8k 1.1× 2.3k 1.3× 1.1k 1.1× 127 11.8k
Tobias M. Hohl United States 52 3.3k 0.6× 3.3k 0.7× 2.5k 0.7× 2.0k 1.1× 375 0.4× 109 8.1k
Amber M. Smith United States 43 5.5k 0.9× 2.3k 0.5× 2.6k 0.7× 2.5k 1.4× 408 0.4× 80 10.2k
Mark R. Alderson United States 56 7.4k 1.2× 2.3k 0.5× 3.3k 0.9× 2.9k 1.6× 687 0.7× 115 12.0k
Peter A. Sieling United States 45 5.3k 0.9× 2.2k 0.5× 2.5k 0.7× 1.7k 0.9× 779 0.8× 84 8.9k
Hardy Kornfeld United States 60 5.4k 0.9× 4.7k 1.0× 4.2k 1.2× 2.8k 1.6× 1.8k 1.9× 179 12.5k

Countries citing papers authored by Shabaana A. Khader

Since Specialization
Citations

This map shows the geographic impact of Shabaana A. Khader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shabaana A. Khader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shabaana A. Khader more than expected).

Fields of papers citing papers by Shabaana A. Khader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shabaana A. Khader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shabaana A. Khader. The network helps show where Shabaana A. Khader may publish in the future.

Co-authorship network of co-authors of Shabaana A. Khader

This figure shows the co-authorship network connecting the top 25 collaborators of Shabaana A. Khader. A scholar is included among the top collaborators of Shabaana A. Khader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shabaana A. Khader. Shabaana A. Khader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Dhiraj Kumar, Mushtaq Ahmed, Sadia Akter, et al.. (2025). Prevention of tuberculosis in cynomolgus macaques by an attenuated Mycobacterium tuberculosis vaccine candidate. Nature Communications. 16(1). 1957–1957. 1 indexed citations
2.
Khan, Nargis, Kim A. Tran, Erwan Pernet, et al.. (2025). β-Glucan reprograms neutrophils to promote disease tolerance against influenza A virus. Nature Immunology. 26(2). 174–187. 17 indexed citations
3.
Ahmed, Mushtaq, Linda D. Hicks, Shannon M. Miller, et al.. (2024). Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses. npj Vaccines. 9(1). 100–100. 10 indexed citations
4.
Thirunavukkarasu, Shyamala, Mushtaq Ahmed, Bruce A. Rosa, et al.. (2023). Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating type I IFN production. Journal of Clinical Investigation. 133(12). 12 indexed citations
5.
Akter, Sadia, Micah Dunlap, José Alberto Choreño-Parra, et al.. (2022). Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes. Cell Reports. 39(12). 110983–110983. 32 indexed citations
6.
Singh, Dhiraj Kumar, Ekaterina Aladyeva, Shibali Das, et al.. (2022). Myeloid cell interferon responses correlate with clearance of SARS-CoV-2. Nature Communications. 13(1). 679–679. 27 indexed citations
7.
Das, Shibali, Nancy D. Marín, Ekaterina Esaulova, et al.. (2021). Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4 + T Cell Activation and Mycobacterium tuberculosis Control. mBio. 12(4). e0146821–e0146821. 11 indexed citations
8.
Sharan, Riti, Shashank Ganatra, Allison N. Bucşan, et al.. (2021). Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model. Journal of Clinical Investigation. 132(3). 12 indexed citations
9.
Chumakov, Konstantin, Michael S. Avidan, Christine Stabell Benn, et al.. (2021). Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics. Proceedings of the National Academy of Sciences. 118(21). 64 indexed citations
10.
Rosa, Bruce A., Mushtaq Ahmed, Dhiraj Kumar Singh, et al.. (2021). IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Communications Biology. 4(1). 290–290. 63 indexed citations
11.
Gharun, Kourosh, Jana Neuber, Julia Kolter, et al.. (2021). Monocyte progenitors give rise to multinucleated giant cells. Nature Communications. 12(1). 2027–2027. 30 indexed citations
12.
Li, Lucy X., Camaron R. Hole, Javier Rangel‐Moreno, Shabaana A. Khader, & Tamara L. Doering. (2020). Cryptococcus neoformans Evades Pulmonary Immunity by Modulating Xylose Precursor Transport. Infection and Immunity. 88(8). 6 indexed citations
13.
Dorhoi, Anca, Leigh A. Kotzé, Jay A. Berzofsky, et al.. (2020). Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus. Journal of Clinical Investigation. 130(6). 2789–2799. 34 indexed citations
14.
Maier, Ezekiel J., Brian C. Haynes, Felipe H. Santiago‐Tirado, et al.. (2016). Computational Analysis Reveals a Key Regulator of Cryptococcal Virulence and Determinant of Host Response. mBio. 7(2). e00313–16. 32 indexed citations
15.
Mehra, Smriti, Taylor W. Foreman, Peter J. Didier, et al.. (2015). The DosR Regulon Modulates Adaptive Immunity and is Essential for Mycobacterium tuberculosis Persistence. American Journal of Respiratory and Critical Care Medicine. 191(10). 1185–1196. 126 indexed citations
16.
Monin, Leticia, Kristin Griffiths, Wing Y. Lam, et al.. (2015). Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis. Journal of Clinical Investigation. 125(12). 4699–4713. 80 indexed citations
17.
Obermajer, Nataša, Jeffrey L. Wong, Robert P. Edwards, et al.. (2013). Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. The Journal of Experimental Medicine. 210(7). 1433–1445. 93 indexed citations
18.
Gopal, Radha, Javier Rangel‐Moreno, Samantha Slight, et al.. (2013). Interleukin-17-dependent CXCL13 mediates mucosal vaccine–induced immunity against tuberculosis. Mucosal Immunology. 6(5). 972–984. 129 indexed citations
19.
Rapaka, Rekha R., David Ricks, John F. Alcorn, et al.. (2010). Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. The Journal of Experimental Medicine. 207(13). 2907–2919. 103 indexed citations
20.
Scheller, Erich V., Keven M. Robinson, Sun Mi Choi, et al.. (2010). Influenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in Mice. The Journal of Immunology. 186(3). 1666–1674. 291 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl G. Feng Breakdown of academic impact, for papers by Javier Rangel‐Moreno Breakdown of academic impact, for papers by Frédéric Altare Breakdown of academic impact, for papers by Maziar Divangahi Breakdown of academic impact, for papers by Samuel M. Behar Breakdown of academic impact, for papers by Tobias M. Hohl Breakdown of academic impact, for papers by Amber M. Smith Breakdown of academic impact, for papers by Mark R. Alderson Breakdown of academic impact, for papers by Peter A. Sieling Breakdown of academic impact, for papers by Hardy Kornfeld
Rankless by CCL
2026